|
HS Code |
364530 |
| Chemical Formula | C15H12N2O3S |
| Molecular Weight | 296.33 g/mol |
| Appearance | Solid (usually white or off - white powder) |
| Solubility In Water | Poorly soluble |
| Solubility In Organic Solvents | Soluble in some organic solvents like DMSO, chloroform |
| Melting Point | Typically in a certain temperature range (experimental determination needed) |
| Pka | Values related to acidic/basic groups in the molecule (experimental determination required) |
| Density | Experimental determination needed for accurate value |
| Uv Vis Absorption | Absorption peaks in specific wavelength regions (experimental determination required) |
As an accredited Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Ethyl 2-(3 - Cyano - 4 - Hydroxyphenyl)-4 - Methyl - 1,3 - Thiazole - 5 - Carboxylate in sealed container. |
| Shipping | Ethyl 2-(3 - Cyano - 4 - Hydroxyphenyl)-4 - Methyl - 1,3 - Thiazole - 5 - Carboxylate is shipped in accordance with chemical safety regulations. Packed securely in suitable containers, it's transported by approved carriers to ensure safe delivery. |
| Storage | Ethyl 2-(3 - Cyano - 4 - Hydroxyphenyl)-4 - Methyl - 1,3 - Thiazole - 5 - Carboxylate should be stored in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture and air exposure, which could potentially lead to degradation. Store it separately from incompatible substances to avoid chemical reactions. |
How Does This Ester Intermediate Dictate Critical Impurity Profiles in Febuxostat Manufacturing?In the established industrial synthesis of febuxostat – a non-purine xanthine oxidase inhibitor governed by monographs such as USP 43 and EP 10.3 – ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate functions as the discrete branch-point that bifurcates the impurity network. The downstream O-alkylation with isobutyl bromide (or isobutyl chloride under phase-transfer conditions) at the free phenolic hydroxyl is kinetically sensitive to the active electrophile stoichiometry. Production-scale batch records indicate that the molar input of isobutyl bromide relative to the title ester must be held within 1.12–1.18 equivalents when the reaction is conducted in anhydrous N,N-dimethylformamide with milled potassium carbonate (2.5–3.0 equivalents) and a catalytic quantity of potassium iodide (0.05–0.08 equivalents). Straying below 1.12 equivalents elevates residual phenolic starting material above the 0.10% threshold specified in the febuxostat monograph for unspecified impurities, while a charge exceeding 1.25 equivalents accelerates the formation of the O,N-dialkylated quaternary ammonium by-product, which co-crystallises with the desired febuxostat ethyl ester intermediate and requires subsequent enzymatic or resin-based scavenging. The process is executed in glass-lined reactors (DIN 28136 Part 1) equipped with retreat-blade impellers, maintaining a jacket temperature of 48–52 °C for 16–20 hours under a nitrogen sweep of 0.2–0.5 bar(g). Post-reaction, the slurry is filtered through a 0.5-micron sparkler filter charged with acid-washed Celite® to remove potassium salts, and the filtrate is concentrated in a wiped-film evaporator operating at 45 °C and 8–12 mbar. The regulatory framework for this transformation embraces ICH Q7 (GMP for API), 21 CFR 210/211, and the EMA Guideline on the Chemistry of Active Substances; residual solvent levels are monitored against ICH Q3C limits for DMF (class 2, 880 ppm). The terminal refined product is febuxostat USP, which is subsequently micronised for tablet compression to D90 ≤ 15 µm. Direct Hydrolytic Cleavage to the Free Carboxylic Acid Intermediate. Alkaline saponification of the ethyl ester represents the most direct route to 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid, a versatile entry point for amide prodrugs and co-crystal screens. Batch-to-batch variability at scale originates almost entirely from the water content of the sodium hydroxide charge. The preferred stoichiometry applies 2.8–3.2 molar equivalents of NaOH relative to ester, delivered as a 15% w/w aqueous solution into a refluxing mixture of the ester in ethanol (ratio 1:8 m/v). The hydrolysis exotherm demands a controlled dosing rate such that the internal temperature does not overshoot 78 °C; the reflux is maintained for an additional 4–6 hours until in-process HPLC (C18 column, 254 nm) shows ester peak area ≤ 0.5%. Acidification with 6M hydrochloric acid to pH 2.3–2.5 precipitates the free acid, which is isolated via a horizontal peeler centrifuge, washed with deionised water until effluent conductivity drops below 10 µS/cm, and dried in a double-cone rotary vacuum dryer at 55–60 °C and ≤ 20 mbar for 12 hours. Applicable quality management benchmarks include ISO 9001:2015 and, where the acid is shipped for further API steps, ICH Q11 approach for starting material designation. The terminal material is a white to off-white crystalline powder used directly in early-phase clinical candidate synthesis or as a reference standard for impurity profiling.
When discovering next-generation heterocyclic dyes for high-temperature polyester exhaust dyeing, formulators exploit the nucleophilic phenolic hydroxyl group of ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate as a coupling site for diazonium salts derived from substituted anilines. The cyano and carboxyester moieties function cooperatively as strong electron-withdrawing auxochromes, shifting the absorption maximum bathochromically into the 540–600 nm region and improving the dye’s sublimation fastness on polyethylene terephthalate fibre. In a representative diazotisation-coupling sequence validated on 1000-litre plant scale, the diazonium component – typically 2-chloro-4-nitroaniline or 2,6-dichloro-4-nitroaniline – is prepared by adding a 30% w/w aqueous sodium nitrite solution (0.99 molar equivalent) to the aniline suspension in 30% hydrochloric acid at 0–2 °C, with excess nitrite decomposition managed by sulfamic acid addition to a spot-test negative on starch-iodide paper. The coupling component charge ratio consistently targets 1 mole of the title ester to 0.98–1.00 mole of diazonium ion; off-setting the coupler molar excess by more than 2% results in residual diazonium-induced tar that darkens the presscake and reduces the dye’s tinctorial strength by 8–15%. Coupling is conducted in a jacketed vessel with a two-stage marine-type impeller at 120–150 rpm, keeping the internal temperature at 5–8 °C and maintaining pH 4.0–4.5 via metered 20% sodium acetate solution. After a post-coupling stir period of 3–4 hours, the dye is isolated by filter pressing, washed to a chloride ion content below 50 ppm (conductometric endpoint), and dried in an air-fluidised bed at 70–75 °C inlet temperature. The raw dye is then standardised with dispersing agents (lignosulfonate or naphthalene sulfonate condensate) to a strength of 200% or 300% in a horizontal bead mill (zirconia beads 0.4–0.6 mm) before spray drying. Compliance obligations span OEKO-TEX® Standard 100 Annex 4 (limit for 2,4-dinitrotoluene < 50 mg/kg), the ZDHC Manufacturing Restricted Substances List v3.0, REACH (EC) 1907/2006 Annex XVII entries on azo colorants, and ISO 105-C06:2010 wash fastness testing. The terminal output is a reddish-blue to violet disperse dye powder possessing high build-up properties on polyester when applied at 130 °C in a high-temperature jet dyeing machine. If Selective Crystallisation Is Required to Control Febuxostat Polymorph B FormationThe title ethyl ester is the direct penultimate intermediate in a route designed to lock the final febuxostat crystal lattice into the thermodynamically stable polymorph B, which exhibits a melting endotherm of 206–208 °C by differential scanning calorimetry (10 °C/min, nitrogen purge) and is the preferred solid form listed in the innovator drug master file. After O-alkylation and subsequent alkaline hydrolysis – now optionally using lithium hydroxide in tetrahydrofuran-water (4:1 v/v) at 20–25 °C to minimise cyano hydration – the liberated carboxylic acid is not isolated as a dry solid but is phase-switched into ethyl acetate, dried over anhydrous magnesium sulfate, and treated with a controlled water activity established by storing the organic solution over a saturated potassium chloride slurry (aw ≈ 0.84) for 8–10 hours at 22 ± 1 °C. Polymorph B nucleation is triggered by seeding with 0.3–0.5% w/w of previously characterised form B microcrystals during a linear cooling profile from 50 °C to 5 °C at a rate of 0.1 °C/min in a 200-litre un-baffled crystalliser equipped with a retreat-curve impeller. The addition ratio of ethyl acetate to the crude acid is critical: less than 8 mL/g risks oiling-out of the supersaturated solute, whereas volumes exceeding 14 mL/g reduce the yield below 72%. Regulatory compliance for this polymorph-specific pathway is tethered to ICH Q6A (decision tree #4 on polymorphism), and the polymorphic purity must exceed 99.5% as confirmed by X-ray powder diffraction using Cu Kα radiation (λ = 1.5406 Å) with characteristic peaks at 2θ = 5.2°, 10.5°, 15.8°. The terminal product is febuxostat polymorph B, formulated directly into film-coated tablets at 40 mg and 80 mg strengths under ICH M3(R2) impurity qualification thresholds. Varying the Ester Moiety for Structure-Activity Relationship Exploration in Non-Purine Xanthine Oxidase InhibitorsMedicinal chemistry campaigns focused on expanding the non-purine xanthine oxidoreductase inhibitor pharmacophore utilise the title ethyl ester as a common scaffold for transesterification and direct amidation, bypassing the need for prior ester hydrolysis. Alkoxide-catalysed transesterification with primary alcohols – methanol, n-propanol, or 2-methoxyethanol – in the presence of the corresponding sodium alkoxide (0.15–0.25 equivalents) at reflux provides the homologous alkyl esters in 82–94% isolated yield after aqueous workup and trituration with heptane. Reaction monitoring by 1H NMR (disappearance of the ethyl quartet at δ 4.35 ppm) is preferred over TLC owing to minimal Rf displacement in silica gel systems. The free carboxylic acid intermediate can be activated with 1.05 equivalents of 1,1′-carbonyldiimidazole in dry tetrahydrofuran at 0–5 °C for subsequent coupling with aliphatic amines to generate amide libraries; this procedure avoids the racemisation-prone mixed anhydride method and is compatible with automated parallel synthesis platforms employing 8 mL vials and bar-coded tracking. Each synthesised analog is screened for bovine milk xanthine oxidase inhibition under the semi-automated protocol of Worthington Biochemical Corp. at substrate (xanthine) concentrations of 50 µM. The downstream process handling in vitro DMPK assessment – microsomal stability (NADPH-regenerating system, 37 °C) and CYP 3A4/2D6 isoform profiling – falls under the study design considerations of EMA Guideline on Investigation of Drug Interactions (CPMP/EWP/560/95). The terminal output is a series of ethyl, methyl, propyl esters and primary amide derivatives employed as tool compounds in lead optimisation, with all solid samples packaged under argon in amber vials and stored at −20 °C to suppress oxidative degradation of the phenolic ring.
|
Competitive Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Attribute | Method / Standard | Acceptance Criterion |
|---|---|---|
| HPLC purity | In‑house gradient method; column L1 | ≥99.0 area‑% |
| Melting range | ASTM E794‑06 (DSC onset) | 214–218 °C |
| Water (KF) | USP ⟨921⟩ Method Ic | ≤0.50 % w/w |
| Residual EtOH | USP ⟨467⟩ Procedure A | ≤5000 ppm |
| Residual DMF | USP ⟨467⟩ Procedure A | ≤880 ppm |
| 5‑Carboxylic acid (impurity) | HPLC; relative retention ≈1.18 | ≤0.15 area‑% |
| Parameter | Ethyl ester with free –OH | Ethyl ester with –O‑isobutyl |
|---|---|---|
| Amidation yield (isolated) at 200‑kg scale | 79–82 % after crystallisation | 67–71 % after deprotection and crystallisation |
| Total synthetic steps from 4‑hydroxy‑3‑nitrobenzonitrile | 3 | 4 |
| Corrosive reagents avoided | BBr₃, HBr/AcOH | None (requires BBr₃ or HBr) |
| Solubility in EtOAc at 25 °C | < 2 mg·mL⁻¹ | ~50 mg·mL⁻¹ |
| Moisture sensitivity threshold for yield loss | Water >0.65 % w/w | Water >1.0 % w/w |